Avanos MedicalAVNS 62 ROC (Joel Greenblatt) % is 13.01% as of Mar. 2026. GuruFocus rates AVNS with a GF Score™ of 62/100 and a GF Value™ of $19.40 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 839 Medical Devices & Instruments companies, Avanos Medical ranks worse than 64.84% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Avanos Medical's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 13.01%.
The historical rank and industry rank for Avanos Medical's ROC (Joel Greenblatt) % or its related term are showing as below:
AVNS'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -131.24 Med: -11.25 Max: 8.78
Current: -21.33
During the past 13 years, Avanos Medical's highest ROC (Joel Greenblatt) % was 8.78%. The lowest was -131.24%. And the median was -11.25%.
AVNS's ROC (Joel Greenblatt) % is ranked worse than 64.84% of 839
companies
in the Medical Devices & Instruments industry
Industry Median: 4.13
vs AVNS: -21.33
Avanos Medical's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
Avanos Medical (NYSE:AVNS) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Avanos Medical ROC (Joel Greenblatt) % Related Terms
Avanos Medical ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Avanos Medical's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AVNS vs LMRI, AORT, IRMD: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Avanos Medical's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Avanos Medical ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Avanos Medical's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Avanos Medical's ROC (Joel Greenblatt) % falls into.
Avanos Medical ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 13.01% mean?
Avanos Medical (AVNS) has a ROC (Joel Greenblatt) % of 13.01% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Avanos Medical and its competitors. According to the industry distribution chart, Avanos Medical ranks #544 out of 839 companies in the Medical Devices & Instruments industry, placing it in the top 64.8%.
Is Avanos Medical's ROC (Joel Greenblatt) % too high?
Avanos Medical's current ROC (Joel Greenblatt) % is 13.01%. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.13. Avanos Medical's value of 13.01% is 215% above this industry median. Based on the distribution chart, Avanos Medical ranks #544 out of 839 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Avanos Medical has a GF Score™ of 62/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Avanos Medical's ROC (Joel Greenblatt) % compare to LMRI and AORT?
According to the Medical Devices & Instruments industry distribution chart, Avanos Medical ranks #544 out of 839 companies for ROC (Joel Greenblatt) %. This places Avanos Medical in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 4.13. Avanos Medical's value of 13.01% is 215% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.13, based on 839 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Avanos Medical's current ROC (Joel Greenblatt) % of 13.01% is 215% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Avanos Medical and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Avanos Medical's current ROC (Joel Greenblatt) % is 13.01%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Avanos Medical stock overvalued right now?
Based on GuruFocus' analysis, Avanos Medical (AVNS) is currently considered Modestly Overvalued. The stock's GF Value™ is $19.40, compared to a current price of $24.92 — trading 28.5% above its estimated fair value. The current ROC (Joel Greenblatt) % is 13.01% and 215% above the Medical Devices & Instruments industry median of 4.13. Avanos Medical's overall GF Score™ is 62/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Avanos Medical (AVNS), the current ROC (Joel Greenblatt) % is 13.01% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Avanos Medical (AVNS) Overvalued in 2026?
Based on GuruFocus' analysis, Avanos Medical stock appears to be overvalued.
The current stock price of $24.92 is trading 28.5% above its estimated GF Value™ of $19.40.
GuruFocus considers Avanos Medical to be Modestly Overvalued.
Key valuation signals for AVNS:
ROC (Joel Greenblatt) %: 13.01%
GF Value™: $19.40 vs. price of $24.92 (28.5% above fair value)
Industry Position: 215% above the Medical Devices & Instruments median (#544 of 839)
No single metric tells the full story. See the AVNS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Avanos Medical Inc is a medical technology company engaged in the development and commercialization of products for pain management and patient care. The company has two reportable segments: Specialty Nutrition Systems and Pain Management and Recovery. The Specialty Nutrition Systems segment provides enteral feeding and neonatal products. The Pain Management and Recovery segment offers surgical pain and recovery products, including pain pumps and radiofrequency ablation solutions for the treatment of chronic pain.
62GF Score
Get the complete analysis for AVNS
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
AVNS has been successfully added to your 
